Modified clostridial toxins with enhanced targeting capabilites for endogenous clostridial toxin receptor systems

Details for Australian Patent Application No. 2012201521 (hide)

Owner Allergan, Inc.

Inventors Fernandez-Salas, Ester; Francis, Joseph; Li, Shengwen; Steward, Lance E.; Gilmore, Marcella A.; Aoki, Kei R.

Agent Davies Collison Cave

Pub. Number AU-A-2012201521

Parent 2006227816

Filing date 14 March 2012

Wipo publication date 5 April 2012

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

Event Publications

29 March 2012 Complete Application Filed

5 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201521

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201522-Wound protector including pocket for reusable distal ring

2012201520-Compounds for enzyme inhibition